Shares of Evonik Industries AG (FRA:EVK) have been given an average rating of “Hold” by the eighteen research firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and ten have assigned a buy rating to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is €28.59 ($33.25).
A number of research analysts recently issued reports on the stock. Deutsche Bank set a €37.00 ($43.02) price target on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Tuesday, January 7th. Kepler Capital Markets set a €23.00 ($26.74) price target on shares of Evonik Industries and gave the stock a “sell” rating in a research note on Tuesday, November 12th. Sanford C. Bernstein set a €30.00 ($34.88) price target on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Monday. Credit Suisse Group set a €25.00 ($29.07) price target on shares of Evonik Industries and gave the stock a “neutral” rating in a research note on Tuesday, November 5th. Finally, DZ Bank reiterated a “buy” rating on shares of Evonik Industries in a research note on Wednesday, November 6th.
Shares of EVK stock traded up €0.22 ($0.26) during trading on Friday, reaching €25.42 ($29.56). The company’s stock had a trading volume of 1,830,253 shares. The stock’s 50-day moving average price is €26.69 and its 200 day moving average price is €24.73. Evonik Industries has a 1-year low of €26.78 ($31.14) and a 1-year high of €32.97 ($38.34).
Evonik Industries Company Profile
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Featured Story: S&P/TSX Index
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.